SMS Pharmaceuticals, a bulk drug manufacturer, is raising funds to augment capacity.
Global pharmaceutical major Teva is planning collaborations with Indian partners for clinical research and biotechnology.
Dr Reddy's on Monday said it would acquire Switzerland-based Roche's bulk drug business in Mexico for $59 million.
'We need to retell this history from many different perspectives.'
Aurobindo Pharma on Thursday said it had received US FDA approval for anti-retroviral Lamivudine, thus enabling it to participate in the president's emergency plan for AIDS relief), a US government initiative.
The court said the Criminal Investigation Department had failed to produce substantial evidence against the accused.
It is domestic policy distortions and inaction to correct them that lie behind the large CADs.
Ankleshwar plant is the third such facility to face action
Real estate firm Ansal Properties and Infrastructure Ltd plans to invest Rs 30,000 crore (Rs 300 billion) to develop 16 townships in north India during next 3-4 years.
Lupin proposes to set up a sector-specific special economic zone in Maharashtra to produce API and formulations with an initial investment of Rs 200 crore (Rs 2 billion).
The stock faced similar trends on the National Stock Exchange as well, where it opened at Rs 362, then plunged 2.70 per cent to an early low of Rs 354.10.
Indian firms selling SAAS products have got a bonanza as companies meet, manage and sell remotely. The top five firms - Zoho, Freshworks HighRadius, Druva, and Icertis - account for 33 per cent of the market share. Chennai, India's SAAS centre, alone generates $1 billion in annual revenue. Yuvraj Malik explains how these companies are planning their next phase of growth.
Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.
Gold, forex assets, IT sector, pharma. Devangshu Datta explains why each of these is a good hedge against market shocks at this time.
'We look forward to providing great customer experiences in India.'
Experts say while the increasing demand for a ban on Chinese goods might make for good optics, the reality is that India is still heavily dependent on that country in a wide range of industries like electronics, mobile devices, auto, pharma, telecom equipment, and fertilisers.
To address the supply crunch, CII has suggested leveraging the existing excess capacity in the Indian industry; rolling back import duty hike to look for alternative sources of imports; expanding credit to manufacturing units with quick loan sanctions, and one-time emergency waiver of non-performing asset regulations for three months.
A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.
An analysis of 3,840 Instagram photos from New York, London, Berlin, Moscow, Bangkok and Sao Paulo - 640 for each city -- found that just four per cent of then were actually selfies.
Lupin Ltd will set up a Rs 100-million plant for manufacturing Lovastatin, a cholesterol lowering active pharmaceutical ingredient, at the company's facilities in Tarapur, Maharashtra.
According to reports, the deal is estimated to be close to $300 mn.
It takes eight to nine months for developing a robust software from the time the rules are decided, warns Bharat Goenka, managing director of Tally Solutions, one of the entities entrusted as a 'Suvidha Provider' with developing ready software for customers to get them ready for the coming Goods and Services Tax.
Lupin Ltd is considering to set up its own marketing force in the United States even as the pharma major is to create a global advisory board as part of its corporate governance initiative.\n\n\n\n
Prajnesh, India's top-ranked singles player at 122, downed the local wild card Jason Kubler 7-5, 6-3 in the first round
The solutions developed by the company cover a broad spectrum, including helping recruiter's gauge the behavioural profiles of candidates during virtual job interviews and assisting in real-time translation in vernacular languages, among others.
Shares of Ranbaxy Laboratories on Friday slumped as much as 20 per cent in the morning trade after the USFDA prohibited the company from producing and distributing drugs for the American market from its Toansa plant in Punjab.
Tamal Bandyopadhyay details HDFC Bank's digital journey.
While critics doubt if the new brand would be continued once Microsoft completes integrating Nokia, the X appears to be Nokia's ploy to ease Android-junkies into a Windows Phone environment.
'What amazes me the most is that today users communicate with voice-activated speakers like as if they were talking to another human being, using words like "please," and "thank you," and even "sorry"!', says advertising guru Sandeep Goyal.
An end to Sun Pharma founder Dilip Shanghvi's woes are not in sight.
The S&P BSE Sensex gained 115 points to end at 24,338 and the Nifty50 climbed 42 points to close at 7,404.
The protection of individual security and privacy is critical to building safe online systems, say Mitchell Baker and Ankit Gadgil.
The recalled drug bottles were distributed by Caraco Pharmaceutical Laboratories, Ltd in the US while manufactured in India by Sun Pharmaceutical Industries Ltd.
